Ordinary People’s Investment & Growth Journal｜Day 119: MSX Launches Phase 3 Pre-IPO Subscription!
I. Web3
1️⃣ Zeroing out—standard procedure. It just so happens I have time to research other projects.
2️⃣ The neighbor has ways to “farm” rewards: 10-88U. But this can’t be posted here; it’s posted on the official account.
3️⃣ MSX has launched Phase 3 Pre-IPO subscriptions, which are Neuralink—the brain-computer interface company under Musk? Anduril AI for defense, a project with a more military background. I previously participated in subscriptions for Spacx and Anthropic—both were profitable projects. What’s interesting this time is that you must have MSX eligibility to participate in the subscription. The minimum is 1,000 MSX, corresponding to a 2,000U quota. Door link https://msx.com/register?code=2jkC08
You can choose a ladder route to Singapore; don’t choose Hong Kong. 29 RMB, no time limit, no device limit. Door link https://yy01.tz86.vip/#/register?code=YAFJ8qTK
II. Hong Kong Stock Pre-IPO Subscriptions
1️⃣ The IPO of Maiketian Medical has launched. A detailed analysis is posted on the official account; if you’re interested, you can participate.
2️⃣ If you haven’t set up a Hong Kong securities account, you can open one with companies like Zhifu or Huili, etc. But remember to first go in person to Hong Kong to get your Hong Kong card. Everyone is welcome to come and play anytime.
III. Other
1️⃣ The gossip in various groups is always about “Sun Ge’s” stuff. Today there’s a turnaround in reputation—people started criticizing Sun Ge. Honestly though, does Sun Ge really fear this? The big shot behind Jingtian is indeed powerful. CZ and Old Xu also jumped in. I don’t understand how these two got involved too. The瓜 (gossip) is getting sweeter. The same-named MeMe has already crashed—are you making money or losing?
2️⃣ The oral RAS inhibitor Daraxonrasib has been approved to treat cancer, and it’s said to work very remarkably. But it costs 260,000 RMB per month—3.2 million per year. Brothers, if you want to live longer, you still need to make more money. Didn’t expect they truly developed it. Technology is becoming more advanced.
3️⃣ If you’re interested in farming rewards, IPO subscriptions, and high-yield financial management, you can join us to find your resonance. One person can move faster; a whole group can go farther.
#空投 #致富证券 #港股打新 #日元跌破160创一个月新低 #麦科田医疗
I. Web3
1️⃣ Zeroing out—standard procedure. It just so happens I have time to research other projects.
2️⃣ The neighbor has ways to “farm” rewards: 10-88U. But this can’t be posted here; it’s posted on the official account.
3️⃣ MSX has launched Phase 3 Pre-IPO subscriptions, which are Neuralink—the brain-computer interface company under Musk? Anduril AI for defense, a project with a more military background. I previously participated in subscriptions for Spacx and Anthropic—both were profitable projects. What’s interesting this time is that you must have MSX eligibility to participate in the subscription. The minimum is 1,000 MSX, corresponding to a 2,000U quota. Door link https://msx.com/register?code=2jkC08
You can choose a ladder route to Singapore; don’t choose Hong Kong. 29 RMB, no time limit, no device limit. Door link https://yy01.tz86.vip/#/register?code=YAFJ8qTK
II. Hong Kong Stock Pre-IPO Subscriptions
1️⃣ The IPO of Maiketian Medical has launched. A detailed analysis is posted on the official account; if you’re interested, you can participate.
2️⃣ If you haven’t set up a Hong Kong securities account, you can open one with companies like Zhifu or Huili, etc. But remember to first go in person to Hong Kong to get your Hong Kong card. Everyone is welcome to come and play anytime.
III. Other
1️⃣ The gossip in various groups is always about “Sun Ge’s” stuff. Today there’s a turnaround in reputation—people started criticizing Sun Ge. Honestly though, does Sun Ge really fear this? The big shot behind Jingtian is indeed powerful. CZ and Old Xu also jumped in. I don’t understand how these two got involved too. The瓜 (gossip) is getting sweeter. The same-named MeMe has already crashed—are you making money or losing?
2️⃣ The oral RAS inhibitor Daraxonrasib has been approved to treat cancer, and it’s said to work very remarkably. But it costs 260,000 RMB per month—3.2 million per year. Brothers, if you want to live longer, you still need to make more money. Didn’t expect they truly developed it. Technology is becoming more advanced.
3️⃣ If you’re interested in farming rewards, IPO subscriptions, and high-yield financial management, you can join us to find your resonance. One person can move faster; a whole group can go farther.
#空投 #致富证券 #港股打新 #日元跌破160创一个月新低 #麦科田医疗
